• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

BD chooses ’embecta’ as new name for Diabetes Care spinoff, confirms leadership team

December 6, 2021 By Sean Whooley

BD Diabetes Spinoff EmbectaBD (NYSE:BDX) announced today that it named its Diabetes Care business — which it plans to spin off next year — “embecta.”

Franklin Lakes, New Jersey-based BD confirmed in May that it plans to spin off its Diabetes Care business as an independent, publicly-traded company during the first half of 2022 and confirmed today that it expects that spinoff to close in the second quarter of the 2022 calendar year.

According to a news release, “embecta” represents the future company’s commitment to helping those with diabetes while paying homage to its corporate heritage. The “em-” prefix refers to empathy for those living with diabetes, while the “bect” embeds part of the Becton Dickinson name into BD’s spinoff.

The logo for embecta fuses two bold, curved lines to form a circle around a single point, symbolizing the idea of bringing people together to form a collaborative, personal relationship, BD said.

“The Diabetes Care business can trace its roots back nearly 100 years to BD’s introduction of the world’s first specialized insulin syringe in 1924 and today is the leading producer of diabetes injection devices in the world,” BD Chairman, CEO & President Tom Polen said in the release. “We’re proud to see that shared legacy reflected in the new name.”

Devdatt Kurdikar, the current Worldwide President of BD Diabetes Care, will become CEO of embecta upon the completion of the spinoff.

Operating under Kurdikar, embecta’s leadership team will include Ginny Blocki as SVP of Product Management & Global Marketing, Tom Blount as SVP & President of North America, Shaun Curtis as SVP of Global Manufacturing & Supply Chain, Jake Elguicze as SVP & CFO, Ajay Kumar as SVP & Chief Human Resources Officer, Jeff Mann as SVP, General Counsel & Head of Corporate Development, Slobodan Radumilo as SVP & President of International and Colleen Riley as SVP & CTO.

BD had previously announced in July that it appointed David F. Melcher and Dr. Claire Pomeroy as directors of the diabetes spinoff.

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: BD, embecta, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS